Pricing Log in Create free account
Saturday 17 October 2026 Export ZBH’s income statement to Excel — free account

Zimmer Biomet Holdings, Inc.

ZBH Healthcare Medical Devices

Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024. In the quarter to June 2026, revenue grew 4.80%, EPS grew 33.8%, free cash flow grew 13.1% and total debt fell 1.23%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five.

95.06 0.68 +0.72%
Market cap
$18.0B
P/E
23.0×
Fwd P/E
17.7×
Dividend yield
1.01%
F-score
6/9
Altman Z
2.38
Beneish M
−2.59
Dividend safety
72/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Zimmer Biomet Holdings, Inc. (ZBH) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, Zimmer Biomet Holdings, Inc. (ZBH) trades at a EV/EBITDA of 11.0×. Over the past ten years it has ranged from 9.9× (May 2026) to 31.6× (November 2015); the current reading is higher than 6% of that period. That is below the Medical Devices industry median of 11.5× and above the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 11.3× (5.10%)
FY2024 11.9× (13.62%)
FY2023 13.8× (17.60%)
FY2022 16.7× (6.51%)
FY2021 17.9× (30.73%)
FY2020 25.8× 52.64%
FY2019 16.9× 20.15%
FY2018 14.1× (9.10%)
FY2017 15.5× (4.59%)
FY2016 16.2× (33.50%)

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 10.2× (5.35%)
Mar 2026 10.8× (4.42%)
Dec 2025 11.3× 3.10%
Sep 2025 10.9× 0.49%
42 more quarters

Against its own ten years

Low 9.9× High 31.6×
Ten-year median 15.8×
Current reading's percentile 6

EV/EBITDA against peers

Company EV/EBITDA
SNN Smith & Nephew SNATS, Inc. compare 6.0×
PHG Koninklijke Philips N.V. compare 8.8×
ZBH Zimmer Biomet Holdings, Inc. 11.0×
GMED Globus Medical, Inc. compare 11.4×
GEHC GE HealthCare Technologies Inc. compare 12.3×
STE STERIS plc compare 14.2×
DXCM DexCom, Inc. compare 23.5×
PEN Penumbra, Inc. compare 58.6×
BIO.B Bio-Rad Laboratories, Inc. compare 176×
Medical Devices industry median 11.5×
Healthcare sector median 9.2×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on ZBH